2. Metabolic Enzyme/Protease
  3. Dipeptidyl Peptidase
  4. 1564241-79-7

1564241-79-7

Baricitinib-d<sub>5</sub> Chemical Structure

1564241-79-7

Chemical Structure

  • Baricitinib-d5
  • Synonym(s): LY3009104-d5;INCB028050-d5
  • CAS No: 1564241-79-7
    Formula: C16H12D5N7O2S
    Molecular Weight: 376.45
  • IUPAC Name: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-((ethyl-d5)sulfonyl)azetidin-3-yl)acetonitrile
  • InChIKey: XUZMWHLSFXCVMG-ZBJDZAJPSA-N
  • SMILES: N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(C([2H])([2H])C([2H])([2H])[2H])=O)C1

Biological Activity: Baricitinib-d5 is the deuterium labeled Baricitinib. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.

Cat. No. Product Name Purity Description
HY-15315S Baricitinib-d5 Baricitinib-d5 is the deuterium labeled Baricitinib. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
HY-15315S1 Baricitinib-d3 ≥99.0% Baricitinib-d3 is the deuterium labeled Baricitinib. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
HY-15315 Baricitinib 99.93% Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
HY-15315R Baricitinib (Standard) ≥98% Baricitinib (Standard) is the analytical standard of Baricitinib. This product is intended for research and analytical applications. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.

Keywords:

Baricitinib-d5Baricitinib-d3BaricitinibBaricitinib (Standard)